ST- GLIPTIN DAPA 50/5

ST-GLIPTIN DAPA 50/5 Tablets are a modern dual-combination therapy developed for the effective management of Type 2 Diabetes Mellitus. This advanced formulation combines two well-established anti-diabetic agents—Dapagliflozin and Sitagliptin—to provide comprehensive glycemic control through complementary mechanisms.

With the rising burden of diabetes in India due to lifestyle changes, unhealthy dietary habits, and genetic predisposition, patients often require combination therapy for better blood sugar management. ST-GLIPTIN DAPA 50/5 offers a convenient and effective once-daily solution that helps control blood glucose levels while supporting overall metabolic health.

Composition & Mechanism of Action

1. Dapagliflozin 5 mg
Dapagliflozin belongs to the class of SGLT2 inhibitors. It works by preventing glucose reabsorption in the kidneys, allowing excess glucose to be excreted through urine. This helps reduce blood sugar levels and may also contribute to mild weight loss.

2. Sitagliptin Phosphate 50 mg
Sitagliptin is a DPP-4 inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin secretion and reduce glucagon levels, thereby maintaining balanced blood glucose levels, especially after meals.

Together, these two components provide a dual-action approach—increasing insulin response and removing excess glucose from the body.

Uses of ST-GLIPTIN DAPA 50/5

ST-GLIPTIN DAPA 50/5 Tablets are indicated for:

• Management of Type 2 Diabetes Mellitus
• Patients not adequately controlled with single-drug therapy
• Improving fasting and postprandial blood sugar levels
• Reducing risk of long-term diabetic complications

It is typically used along with a healthy diet and regular physical activity.

Benefits of ST-GLIPTIN DAPA 50/5

1. Dual Mechanism for Better Control
Targets different pathways to provide effective and sustained glycemic control.

2. Improves HbA1c Levels
Helps significantly reduce long-term blood glucose markers.

3. Supports Weight Management
Dapagliflozin aids in eliminating excess glucose, which may help in weight control.

4. Low Risk of Hypoglycemia
Compared to some traditional therapies, it has a lower risk of causing low blood sugar.

5. Convenient Once-Daily Dosage
Improves patient compliance and ease of use.

6. Cardiometabolic Benefits
Supports overall metabolic health and may reduce cardiovascular risk factors.

Dosage & Administration

• Take ST-GLIPTIN DAPA 50/5 Tablets as prescribed by your doctor.
• Usually taken once daily, with or without food.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.
• Follow a consistent dosing schedule for best results.

Side Effects

While generally well tolerated, some patients may experience:

Common Side Effects:

• Frequent urination
• Thirst or dehydration
• Headache
• Nasopharyngitis

Less Common Side Effects:

• Urinary tract infections
• Genital infections
• Mild gastrointestinal discomfort

Serious Side Effects (Rare):

• Severe allergic reactions
• Kidney-related issues
• Pancreatitis (rare with Sitagliptin)

Seek medical attention if any severe symptoms occur.

Precautions & Warnings

Before using ST-GLIPTIN DAPA 50/5, inform your doctor if you have:

• Kidney or liver disease
• History of pancreatitis
• Recurrent urinary infections
• Heart disease
• Dehydration

Important Safety Advice:

• Maintain proper hydration
• Monitor blood sugar levels regularly
• Avoid excessive alcohol consumption
• Follow a diabetic-friendly diet

Pregnancy & Breastfeeding:

• Use only if prescribed by a healthcare professional
• Not recommended without medical supervision

Drug Interactions

ST-GLIPTIN DAPA 50/5 may interact with:

• Insulin or other anti-diabetic drugs
• Diuretics
• Blood pressure medications
• Certain antibiotics

Always inform your doctor about all medications you are taking.

Storage Instructions

• Store in a cool, dry place below 25°C
• Protect from light and moisture
• Keep out of reach of children

Why Choose ST-GLIPTIN DAPA 50/5 Tablets?

ST-GLIPTIN DAPA 50/5 Tablets offer a balanced and effective solution for patients who require combination therapy for diabetes management. Its dual-action mechanism ensures better glycemic control while minimizing the risk of side effects.

Healthcare professionals prefer this combination for its proven efficacy, safety profile, and ability to improve patient adherence through simplified dosing.

Conclusion

ST-GLIPTIN DAPA 50/5 Tablets (Dapagliflozin 5 mg & Sitagliptin 50 mg) provide a comprehensive and modern approach to managing Type 2 Diabetes Mellitus. By combining two powerful anti-diabetic agents, it helps control blood sugar levels effectively and supports long-term health outcomes.

For best results, this medication should be taken under medical supervision along with lifestyle modifications such as a balanced diet and regular exercise. ST-GLIPTIN DAPA 50/5 stands as a reliable choice for effective diabetes care in today’s healthcare environment.